Pharmaceutical Targeting of Lipids in Metabolic and Neurological Disorders
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmacology".
Deadline for manuscript submissions: 30 November 2026 | Viewed by 1231
Editors
Interests: metabolic disorders; lipid metabolism; neuroregeneration
Special Issue Information
Dear Colleagues,
Lipids play a pivotal role in maintaining cellular structure, signaling, and energy metabolism, and their dysregulation is increasingly recognized as a central factor in the pathogenesis of numerous metabolic and neurological disorders. Growing evidence links disturbances in lipid metabolism with conditions such as type 2 diabetes, obesity, Alzheimer’s and Parkinson’s disease, and multiple sclerosis. This Special Issue aims to gather research elucidating the molecular mechanisms underlying lipid imbalance and its pharmacological modulation. We welcome studies exploring novel therapeutic strategies, lipid signaling pathways, drug development targeting lipid-related enzymes and receptors, as well as translational approaches that bridge metabolic and neurological dysfunctions. The goal is to foster interdisciplinary collaboration among lipid biochemistry, pharmacology, neuroscience, and clinical medicine to advance lipid-based therapeutic innovations.Lipids play a pivotal role in maintaining cellular structure, signaling, and energy metabolism, and their dysregulation is increasingly recognized as a central factor in the pathogenesis of numerous metabolic and neurological disorders. Growing evidence links disturbances in lipid metabolism with conditions such as type 2 diabetes, obesity, Alzheimer’s and Parkinson’s disease, and multiple sclerosis. This Special Issue aims to gather research elucidating the molecular mechanisms underlying lipid imbalance and its pharmacological modulation. We welcome studies exploring novel therapeutic strategies, lipid signaling pathways, drug development targeting lipid-related enzymes and receptors, as well as translational approaches that bridge metabolic and neurological dysfunctions. The goal is to foster interdisciplinary collaboration among lipid biochemistry, pharmacology, neuroscience, and clinical medicine to advance lipid-based therapeutic innovations.
Dr. Senka Blažetić
Dr. Barbara Viljetić
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- lipid metabolism
- pharmacological targets
- metabolic disorders
- neurodegenerative diseases
- lipid signaling
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
